Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Potent inhibition of human PDE4 reported for new Kyowa Hakko compound

April 12, 2000

LeukoSite and Kyowa Hakko collaborate on the design of chemokine receptor antagonists

April 11, 2000

Bayer obtains first approval worldwide for new antiallergic agent

April 11, 2000

TBC-3342: a potent urea VLA-4 antagonist designed at Texas Biotechnology

April 10, 2000

Small-molecule chemokine receptor antagonists jointly developed by LeukoSite and Kyowa Hakko

April 10, 2000

RP105 antagonists and their use described by SmithKline Beecham

April 6, 2000

Immunosuppressive agents and their use in airways diseases

April 6, 2000

Newly formed company to market TOBI in the Dutch market

April 5, 2000

Licensing opportunity from NIH: adenovirus-mediated gene therapy

April 4, 2000

Binding, functional and pharmacological characterization of R-113281

April 4, 2000

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...